Title:
MULTIPLE FORMULATION OF TICAGRELOR
Document Type and Number:
WIPO Patent Application WO/2021/197451
Kind Code:
A1
Abstract:
A multiple formulation for once-a-day administration of ticagrelor or a pharmaceutically acceptable salt thereof, said multiple formulation comprising an immediate-release multiple unit portion and a sustained-release multiple unit portion, the immediate-release multiple unit portion consisting of separate immediate-release units and the sustained-release multiple unit portion consisting of separate sustained-release units, each unit comprising the multiple formulation having a maximum diameter of less than 5.0 mm.
Inventors:
ZHANG QIANG (CN)
CHEN HAO (CN)
CAO XIUXIU (CN)
HE HUA (CN)
WANG JIE (CN)
LU YUN (CN)
CHEN HAO (CN)
CAO XIUXIU (CN)
HE HUA (CN)
WANG JIE (CN)
LU YUN (CN)
Application Number:
PCT/CN2021/085154
Publication Date:
October 07, 2021
Filing Date:
April 02, 2021
Export Citation:
Assignee:
JIANGSU HENGRUI MEDICINE CO (CN)
International Classes:
A61K9/22; A61K9/48; A61K31/519; A61P7/02; A61P9/10
Foreign References:
| CN110507624A | 2019-11-29 | |||
| CN106074357A | 2016-11-09 |
Attorney, Agent or Firm:
GE CHENG & CO.,LTD. (CN)
Download PDF:
Previous Patent: GAS-LIQUID SEPARATOR AND HEAT MANAGEMENT SYSTEM
Next Patent: CRYSTAL FORM OF FREE ALKALI OF NITROGEN-CONTAINING AROMATIC DERIVATIVES
Next Patent: CRYSTAL FORM OF FREE ALKALI OF NITROGEN-CONTAINING AROMATIC DERIVATIVES